
Clinical Human Cancer FFPE Tissue Characterization for Clinical Studies (TCHZ)
Clinical Development and Assay Validation (CDAV)

Clinical Biomarker Assessment and Scoring Development (BASD) and Establishment of guidelines for the methodology and criteria of tissue biomarker testing in biomarker-driven clinical trials.

Clinical Biomarker Scoring System (CBSS)

Clinical Pathology Algorithm and Biomarker cut-off determination studies (CPAD)

Clinical Biomarker Interpretation Development (CBID): An expert pathology interpretation guide development.
CanTar® Discover For Pharma: Cutting-edge Translational Pathology and Target Discovery Services for Pharmaceutical and Biotech companies. All Rights Reserved. Copyright © 2026
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.